60 Degrees Pharmaceuticals, Inc. (SXTP)

NASDAQ: SXTP · Real-Time Price · USD

1.202

-0.028 (-2.32%)

Nov 13, 2025, 1:06 PM EST - Market open

SXTP Employees

60 Degrees Pharmaceuticals had 3 employees as of December 31, 2024. The number of employees did not change compared to the previous year.

Employees

3

Change (1Y)

n/a

Growth (1Y)

n/a

Revenue / Employee

$328,165

Profits / Employee

-$2,769,166

Market Cap

4.93M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	3	0	-
Dec 31, 2023	3	1	50.00%
Dec 31, 2022	2	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

SXTP News

4 weeks ago - 60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study - GlobeNewsWire
5 weeks ago - 60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study - GlobeNewsWire
2 months ago - 60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
3 months ago - 60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
3 months ago - 60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis - GlobeNewsWire
3 months ago - 60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results - GlobeNewsWire
4 months ago - 60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering - GlobeNewsWire
4 months ago - 60 Degrees Pharmaceuticals Announces Pricing of Up to $10 Million Public Offering - GlobeNewsWire